Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
04.09. | MEXEDIA S.P.A: Mexedia a SiGMA Euro-Med 2025: gli SMS al centro della customer experience nell'iGaming | ||
04.09. | MEXEDIA S.P.A: Mexedia at SiGMA Euro-Med 2025: SMS at the Core of Customer Experience in iGaming | ||
04.09. | COMPAGNIE DU BOIS SAUVAGE: Results H1 2025 | ||
04.09. | ACCOR: Disclosure of shares outstanding and voting rights - 04.09.2025 | ||
04.09. | EURAZEO SE: Disclosure of the number of shares and the total number of voting rights as of August 31, 2025 | ||
04.09. | EDENRED: Disclosure of Share Capital and Voting Rights as of August 31, 2025 | ||
04.09. | DEEZER: Deezer named to Newsweek's list of the world's most trustworthy companies in 2025 | ||
04.09. | SHURGARD: 20250904 Shurgard signs new purchase agreement in Hoorn, Randstad, NL | ||
04.09. | FACEPHI: Facephi Named Representative Vendor by Gartner® in the Market Guide for User Authentication 2025 | ||
04.09. | CRESCENT N.V.: REGULATED INFORMATION - Disclosure on a transparency notification (Article 14(1) of the Law of 2 May 2007 on disclosure of major shareholdings) | ||
04.09. | CVC CAPITAL: CVC Capital Partners plc - Half-Year Results | ||
04.09. | PEUGEOT INVEST: Peugeot Invest successfully completes the sale of 5.8% of LISI's share capital | ||
04.09. | BIOMERIEUX: bioMérieux - First-Half 2025 Results | ||
03.09. | DERICHEBOURG: Launch of a sharebuyback program | ||
03.09. | TF1: Monthly disclosure of the total number of shares and voting rights - August 2025 | ||
03.09. | OPMOBILITY: Declaration of voting rights at the end of August 2025 | ||
03.09. | ADP: Aéroports de Paris SA - Shares and voting rights as of 31 August 2025 | ||
03.09. | PEUGEOT INVEST: Peugeot Invest initiates the disposal of a 5.8% stake in LISI | ||
03.09. | Rebirth S.p.A.: REBIRTH S.p.A. announces the approval of the merger plan of LO.DA. Immobiliare S.r.l. | ||
03.09. | SHURGARD: 20250902 - Shurgard obtains new building permit in Bonn DE | ||
03.09. | PROSUS: Update of repurchase programme | ||
03.09. | BIOPHYTIS: Biophytis obtains EMA authorization to launch its Phase 2 clinical trial in obesity | ||
02.09. | DERICHEBOURG: Update of the EBITDA target for the 2025 fiscal year | ||
02.09. | CARE PROPERTY INVEST: Publication Half-yearly financial report 2025 | ||
02.09. | CARREFOUR: Information concerning the total number of voting rights and shares 2025 08 31 |